BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27806941)

  • 1. Coexpressed High Levels of VEGF-C and Active MMP-9 Are Associated With Lymphatic Spreading and Local Invasiveness of Papillary Thyroid Carcinoma.
    Šelemetjev S; Ðoric I; Paunovic I; Tatic S; Cvejic D
    Am J Clin Pathol; 2016 Nov; 146(5):594-602. PubMed ID: 27806941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical levels of cyclo-oxygenase-2, matrix metalloproteinase-9 and vascular endothelial growth factor in papillary thyroid carcinoma and their clinicopathological correlations.
    Meng XY; Zhang Q; Li Q; Lin S; Li J
    J Int Med Res; 2014 Jun; 42(3):619-27. PubMed ID: 24670538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant high expression of survivin and vascular endothelial growth factor-C is strongly associated with metastatic status of lymph nodes in papillary thyroid carcinoma.
    Selemetjev S; Savin S; Paunovic I; Tatic S; Cvejic D
    J Cancer Res Ther; 2018; 14(Supplement):S114-S119. PubMed ID: 29578160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of TGF-β1, SNAI1 and MMP-9 is associated with lymph node metastasis in papillary thyroid carcinoma.
    Wang N; Jiang R; Yang JY; Tang C; Yang L; Xu M; Jiang QF; Liu ZM
    J Mol Histol; 2014 Aug; 45(4):391-9. PubMed ID: 24276590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-regulatory potential of vascular endothelial growth factor-A and vascular endothelial growth factor-C in thyroid carcinoma.
    Salajegheh A; Pakneshan S; Rahman A; Dolan-Evans E; Zhang S; Kwong E; Gopalan V; Lo CY; Smith RA; Lam AK
    Hum Pathol; 2013 Oct; 44(10):2204-12. PubMed ID: 23845470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathologic study of expression and significance of matrix metalloproteinases-9, tissue inhibitor of metalloproteinase-1, vascular endothelial growth factor and transforming growth factor beta-1 in papillary carcinoma and follicular carcinoma of thyroid].
    Wang T; Jiang CX; Li Y; Liu X
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):824-8. PubMed ID: 20193458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical levels of matrix metalloproteinase-2 and CD44 variant 6 protein in the diagnosis and lateral cervical lymph node metastasis of papillary thyroid carcinoma.
    Wu G; Zhou Y; Li T; Guo J; Zhou Z
    J Int Med Res; 2013 Jun; 41(3):816-24. PubMed ID: 23685894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced activation of matrix metalloproteinase-9 correlates with the degree of papillary thyroid carcinoma infiltration.
    Marecko I; Cvejic D; Selemetjev S; Paskas S; Tatic S; Paunovic I; Savin S
    Croat Med J; 2014 Apr; 55(2):128-37. PubMed ID: 24778099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between protein expression of VEGF-C, MMP-2 and lymph node metastasis in papillary thyroid cancer.
    Tian X; Cong M; Zhou W; Zhu J; Liu Q
    J Int Med Res; 2008; 36(4):699-703. PubMed ID: 18652765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of biomarkers for clinical diagnosis of papillary thyroid carcinoma with distant metastasis.
    Liang H; Zhong Y; Luo Z; Huang Y; Lin H; Luo M; Zhan S; Xie K; Ma Y; Li QQ
    Int J Biol Markers; 2010; 25(1):38-45. PubMed ID: 20306451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrix metalloproteinase-2 and its tissue inhibitor-2 in fetal and neoplastic thyroid tissue and their significance as diagnostic and prognostic markers in papillary carcinoma.
    Marečko I; Cvejić D; Tatić S; Dragutinović V; Paunović I; Savin S
    Cancer Biomark; 2011-2012; 11(1):49-58. PubMed ID: 22820140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
    Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM
    Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative plasma concentrations of vascular endothelial growth factor and matrix metalloproteinase 9 are associated with stage progression in papillary thyroid cancer.
    Lin SY; Wang YY; Sheu WH
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):513-8. PubMed ID: 12641636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of hypoxia-inducible factor 1 alpha in papillary thyroid carcinoma is associated with desmoplastic stromal reaction and lymph node metastasis.
    Koperek O; Akin E; Asari R; Niederle B; Neuhold N
    Virchows Arch; 2013 Dec; 463(6):795-802. PubMed ID: 24197448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the ROCK1/MMP-9 pathway is associated with the invasion and poor prognosis in papillary thyroid carcinoma.
    Luo D; Chen H; Li X; Lu P; Long M; Peng X; Lin S; Tan L; Zhu Y; Ouyang N; Li H
    Int J Oncol; 2017 Oct; 51(4):1209-1218. PubMed ID: 28848996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
    Jiang XL; Zhang H; Chen YL; Peng L
    Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of survivin expression and its prognostic value in papillary thyroid carcinoma.
    Selemetjev S; Dencic TI; Marecko I; Jankovic J; Paunovic I; Savin S; Cvejic D
    Pathol Res Pract; 2014 Jan; 210(1):30-4. PubMed ID: 24199968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor overexpression is a marker for adverse pathologic features in papillary thyroid carcinoma.
    Fisher KE; Jani JC; Fisher SB; Foulks C; Hill CE; Weber CJ; Cohen C; Sharma J
    J Surg Res; 2013 Nov; 185(1):217-24. PubMed ID: 23746767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic significance of elevated expression of HBME-1 in papillary thyroid carcinoma.
    Chen YJ; Zhao RM; Zhao Q; Li BY; Ma QY; Li X; Chen X
    Tumour Biol; 2016 Jul; 37(7):8715-20. PubMed ID: 26738867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cytokeratin-19 (CK19) in the classical subtype of papillary thyroid carcinoma: the experience of one center in the Silesian region.
    Kaliszewski K; Diakowska D; Strutynska-Karpinska M; Rzeszutko M; Grzegrzolka J; Dziegiel P; Wojtczak B; Sutkowski K
    Folia Histochem Cytobiol; 2016; 54(4):193-201. PubMed ID: 28051274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.